Novartis loses patent battle in India: Time to realign the business model to emerging markets?
On April 1, 2013, the Supreme Court of India rejected Novartis’ patent application for its cancer treatment drug, Glivec. Novartis had applied for patent protection in 2006, and after a seven-year legal battle, it all ended in disappointment for the Swiss pharmaceutical company. Public opinion seeme...
Saved in:
Main Authors: | , , |
---|---|
Format: | text |
Language: | English |
Published: |
Institutional Knowledge at Singapore Management University
2013
|
Subjects: | |
Online Access: | https://ink.library.smu.edu.sg/cases_coll_all/54 https://cmp.smu.edu.sg/case/2601 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Singapore Management University |
Language: | English |